Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Immune Thrombocytopenia”

149 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 149 results

Not applicableNot Yet RecruitingNCT07146555
What this trial is testing

Vitamin D Satus in Adults With Newly Diagnosed ITP

Who this might be right for
Vitamin D Concentration
Assiut University 84
Large-scale testing (Phase 3)Ended earlyNCT04224688
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
UCB Biopharma SRL 30
Not applicableNot Yet RecruitingNCT07182760
What this trial is testing

Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenic PurpuraAmegakaryocytic AplasiaUnilineage Myelodysplastic Syndrome ( Megakaryocyte Dysplasia)+2 more
Assiut University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07196163
What this trial is testing

An Exploratory Study of Golidocitinib in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Peking University People's Hospital 138
Testing effectiveness (Phase 2)Study completedNCT04669600
What this trial is testing

A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia (ITP)
Bioverativ, a Sanofi company 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05369364
What this trial is testing

The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 150
Large-scale testing (Phase 3)Study completedNCT04070599
What this trial is testing

Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.

Who this might be right for
Immune Thrombocytopenic PurpuraAutoimmune ThrombocytopeniaThrombopenia
University Hospital, Bordeaux 70
Testing effectiveness (Phase 2)Looking for participantsNCT06992128
What this trial is testing

Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 129
Not applicableStudy completedNCT01013181
What this trial is testing

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults

Who this might be right for
Thrombopenia
Henri Mondor University Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT07039422
What this trial is testing

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Who this might be right for
Primary Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00424177
What this trial is testing

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Large-scale testing (Phase 3)Looking for participantsNCT06948318
What this trial is testing

A Continuation Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Takeda 150
Large-scale testing (Phase 3)Study completedNCT00370331
What this trial is testing

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 197
Large-scale testing (Phase 3)Looking for participantsNCT04915482
What this trial is testing

TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Who this might be right for
Immune Thrombocytopenia (ITP)AutoantibodiesEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China 94
Testing effectiveness (Phase 2)Study completedNCT00706342
What this trial is testing

Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Rigel Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT04278924
What this trial is testing

TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Takeda 41
Testing effectiveness (Phase 2)Study completedNCT00002665
What this trial is testing

SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia

Who this might be right for
LeukemiaNeutropeniaThrombocytopenia
SWOG Cancer Research Network 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03395210
What this trial is testing

Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 86
Testing effectiveness (Phase 2)Study completedNCT02273960
What this trial is testing

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Bristol-Myers Squibb 46
Load More Results